- Conditions
- Adjuvant Treatment, NSCLC
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen University Cancer Center Guangdong, Guangzhou, China
Clinical trial condition
Adjuvant Treatment
Explore clinical trials studying Adjuvant Treatment. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Adjuvant Treatment trial results
NCT07071038
- Conditions
- Adjuvant Treatment, Breast Cancer, Breast Diseases, +6 more
- Locations
-
- Dartmouth Cancer Center Lebanon, New Hampshire, United States
Not yet recruiting
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07507916
- Conditions
- Adenocarcinoma, Adjuvant Treatment, Carcinoma, +13 more
- Locations
-
Not specified
Not yet recruiting
Iparomlimab and Tuvonralimab Injection (QL1706) Combined With Bevacizumab for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma (HCC) With High Risk of Recurrence
NCT06958484
- Conditions
- Adenocarcinoma, Adjuvant Treatment, Carcinoma, +10 more
- Locations
-
Not specified
Not yet recruiting
The Efficacy and Safety of Ensartinib As Adjuvant Therapy in Stage I ALK-positive NSCLC Patients with High Risk Factors
NCT06772610
- Conditions
- ALK, Adjuvant Treatment, NSCLC, +1 more
- Locations
-
Not specified
Not yet recruiting
Adjuvant Treatment of Digestive Tract Tumors
NCT05742620
- Conditions
- Adjuvant Treatment
- Locations
-
Not specified
Active, not recruiting
One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491
- Conditions
- Adjuvant Treatment, Melanoma, Melanoma, Skin, +11 more
- Locations
-
- CHRU Nancy Vandœuvre-lès-Nancy, Grand Est, France
NCT05100277
- Conditions
- Adjuvant Treatment, Breast Cancer, Breast Diseases, +5 more
- Locations
-
- Andre Mattar São Paulo, Brazil